期刊文献+

尼莫地平速释微丸及缓释微丸的制备 被引量:13

Preparations of immediate-release and sustained-release pellets of niomdipine
下载PDF
导出
摘要 目的研究尼莫地平速释微丸及缓释微丸的制备方法。方法通过溶剂蒸发-沉积法制备尼莫地平速释型及缓释型固体分散体;应用挤出-滚圆技术和离心造粒技术制备尼莫地平速释微丸及缓释微丸。结果依据处方1、2、3,采用挤出-滚圆技术制得的尼莫地平缓释微丸于1、3、5、12、18h的累积溶出百分率分别为18%、34%、49%、79%、100%;12%、18%、24%、36%、51%;42%、55%、61%、90%、100%。依据处方4、5得到速释微丸于45、90 min的累积溶出百分率分别为92%、100%;80%、89%,符合速释制剂的溶出要求。由处方6、7制备的缓释微丸于1、3、5、12、18h的累积溶出百分率分别为35%、48%、53%、77%、92%;30%、40%、47%、56%、80%。结论以国家食品药品监督管理局国家药品标准WS1-(X-171)-2003Z为依据设计的尼莫地平微丸处方较理想,制备工艺简单易行,值得广泛应用于尼莫地平微丸的工业生产。 Objective To develop the methods for the preparation of immediate-release and sustained-release pellets of nimodipine. Methods The centrifugal granulation technology, extrusion-spheronization technology and fluid bed spray processor were used to prepare the nimodipine pellets. The solvent evaporation-deposi- tion method was selected to prepare the solid dispersion of nimodipine. Results The sustained-release pellets of nimodipine prepared by extrusion-spheronization technology had accumulated release rates of 18 %, 34 %, 49 %, 79 %, 100 % after 1, 3, 5, 12, 18 hfor formulation 1, 12 %, 18 %, 24 %, 36 %, 51% for formulation 2, and 42 %, 55 %, 61%, 90 %, 100 % for formulation 3, respectively. The immediate- release pellets of nimodipine based on formulation 4, 5 released 92 %, 100 % after 45, 90 min respectively and the requirement for the release of immediate-release preparation at the two measuring points were 80 %, 89 % respectively. The accumulated release rates of sustained-release pellets of nimodipine(formulation 6, 7)after 1, 3, 5, 12, 18 h were 35 %, 48 %, 53 %, 77 %, 92 % and 30 %, 40 %, 47 %, 56 %, 80 %, respectively. Conclusions The formulations and methods for the preparation of nimodipine pellets may reach the expected goals. The preparations were simple and feasible. They are worth further development for the industrial applications.
出处 《沈阳药科大学学报》 CAS CSCD 北大核心 2007年第2期74-78,共5页 Journal of Shenyang Pharmaceutical University
关键词 尼莫地平 固体分散体 速释微丸 缓释微丸 挤出-滚圆法 离心造粒法 nimodipine solid-dispersion immediate- release pellet sustained-release pellet extrusionspheronization centrifugal granulation
  • 相关文献

参考文献8

  • 1刘海峡.尼莫地平的临床应用[J].河南实用神经疾病杂志,2000,3(6):60-61.
  • 2FABRIZIO F, CRISTINA F, ELDA D G, et al. Nimodipine selectively stimulates β-amyloid 1-42 secretion by a mechanism independent of ealeium influx blockage[J]. Neurobiology of Aging, 2006, 27(2) :218 - 227.
  • 3PATRIZIA B, RENATO U, DE ARIANNA L, et al.Nimodipine: Drug pharmacokinetics and plasma adenosine levels in patients affected by cerebral ischemia [J].Clinical Pharmacology & Therapeutics, 2002, 72 ( 5 ) :556- 561.
  • 4ISSAC C S. Pharmaceutical pelletization technology[ M]. New York: Marcel Dekker Inc, 1989:101- 143.
  • 5NESBITT R U, MAHJOUR M, NANCY L M, et al.Effect of substrate on mass release latex coated pellets[ J ]. J Control Release, 1994, 32 ( 1 ) : 71 - 77.
  • 6朴龙奎.离心造粒机的半自动造粒论[J].中国药学杂志,1990,25(1):34-37. 被引量:9
  • 7王文刚,崔光华.挤出-滚圆制微丸工艺的进展[J].中国新药杂志,2001,10(9):661-664. 被引量:51
  • 8MOHAMMED A. Al-Omar nimodipine: Drug metabolism and pharmacokinetic profile [ J ]. Profiles of Drug Substances, Exeipients and Related Methodology,2005(31) :371 - 375.

二级参考文献2

共引文献58

同被引文献97

引证文献13

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部